The independent platform for news, articles and advice for professionals in laboratory medicine

RECENT NEWS

Atom Scientific brings Falc products to the UK

Atom Scientific has announced a new distribution partnership with Falc Instruments for the UK, adding the Italian company’s laboratory equipment to its already extensive range.

NGS shows promise in expanding immunotherapy to more cancer patients

Research into next-generation sequencing carried out at Brigham and Women’s Hospital suggests that revising current cancer care guidelines could allow approximately 6,000 more patients in the US to benefit from immunotherapy treatment each year.

UK NSC endorses digital pathology

The UK National Screening Committee (UK NSC) has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.

NHS warns of tough new year amid growing winter pressures and record strike action

Record industrial action this week could see one of the most difficult starts to the year for health services across the country, the NHS has said.

Aiforia and the Mayo Clinic using AI to improve prediction of colorectal cancer recurrence

Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialise an AI model that improves prediction of colorectal cancer recurrence. The AI model - developed in collaboration with the Mayo Clinic - identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for colorectal cancer treatment decisions.

Roche to acquire LumiraDx's point-of-care technology

Roche has entered into a definitive agreement to acquire select parts of the LumiraDx group, related to LumiraDx’s innovative point-of-care technology. Following closing of the transaction, which is expected by mid-2024, the acquired entities will be fully integrated into Roche Diagnostics.

2023: A record-breaking year for NHS cancer checks

More people than ever before are getting tested for cancer with almost three million checks over the last 12 months, new analysis shows.

New type of antibody shows promise against multiple forms of influenza virus

Researchers have identified a previously unrecognised class of antibodies that appear capable of neutralising multiple forms of influenza virus. These findings, which could contribute to development of more broadly protective vaccines, were published 21 December by Holly Simmons of the University of Pittsburgh School of Medicine, US, and colleagues in the open access journal PLOS Biology.

A new dataset for tumours of the lung

The International Academy of Cytology and the International Collaboration on Cancer Reporting have announced the publication of a new dataset to assist reporting of Tumours of the Lung - Small Diagnostic and Cytopathlogical Specimens.

NHS trials home testing for chronic kidney disease

Tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes as part of a £30 million tech and AI innovation fund this winter. The Healthy.io early detection device will initially be sent to 30,000 patients who are considered most at risk for kidney disease.

AMP publishes best practice guidance on slice testing approach to diagnostics

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, has published a report that explores specific considerations for a slice testing strategy for diagnostics, including gene selection, analytic performance, coverage, quality, and interpretation.

Owkin and MSD to develop AI-powered diagnostics for cancer

Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, has entered into a collaboration agreement with MSD (the tradename of Merck & Co) to develop and commercialise AI-powered digital pathology diagnostics for the EU market.

Metrion Biosciences closes £3.7 million new equity financing

Metrion Biosciences, the specialist ion channel CRO and drug discovery company, has announced that it has secured £3.5m in new equity financing. The new investment will be used to further expand Metrion’s laboratories in Cambridge, UK, invest in specialist equipment and enhance the company’s global marketing activities.

NHS expands home testing for bowel cancer

The NHS is expanding home testing for bowel cancer as it aims to detect the disease earlier. Hundreds of thousands more people will be sent a home-testing kit as the lifesaving screening programme is now being made available to individuals aged 54 in England.

CardioRenal unveils world-first use of blood potassium self-tests by patients

CardioRenal and Grenoble Alpes University Hospital have unveiled a major innovation that allows chronically ill patients to measure their blood potassium levels autonomously and accurately. The TENOR device enables patients to measure their blood potassium levels at home, similar to how diabetic patients have conducted blood sugar self-tests for many years.

Environmental destruction and migration increases spread of pathogens

New links between human activity and its impact on the emergence of viruses within parasites in the rainforests of Peru and Bolivia have been discovered, according to a paper authored by researchers from the Institute of Tropical Medicine (ITM) in Antwerp and the Rega Institute for Medical Research (KU Leuven) who are investigating the spread of tropical diseases.

Two Northern Ireland Trusts go live with Clinisys Winpath

Two Health and Social Care Trusts in Northern Ireland have gone live with Clinisys WinPath, at the start of a series of deployments from the Core LIMS project. This project, which is being led by the Business Services Organisation (BSO), will see every pathology service in Northern Ireland adopt the laboratory information system to support the modernisation of services.

AstraZeneca to acquire vaccine developer Icosavax

AstraZeneca has entered into a definitive agreement to acquire Icosavax, a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines. It will give AstraZenica rights to a vaccine candidate targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), which is currently on its way into Phase III testing.

Greiner Bio-One adds 96-well option to ThinCert portfolio

Tried-and-tested ThinCert cell culture inserts from Greiner Bio-One are now available in a new 96-well HTS option, perfect for high-throughput applications. The new product joins the company’s popular 6-, 12- and 24-well options in the range, which is suitable for sophisticated cell and tissue culture applications.

UKRI funding global vaccine networks tackling infections

The global vaccine networks will continue their vital work for a further two years with funding granted by UK Research and Innovation (UKRI), from the International Science Partnerships Fund.

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025